Corvus Pharmaceuticals, Inc.
METHODS FOR TREATING CD73HI TUMORS
Last updated:
Abstract:
Provided herein are, inter alia, 1E9 antibodies capable of binding CD73. The humanized antibodies are useful for the treatment of cancer in a subject expressing elevated levels of CD73.
Status:
Application
Type:
Utility
Filling date:
4 Apr 2018
Issue date:
15 Apr 2021